Back to Results
First PageMeta Content
Health / Pharmaceutical industry / Food and Drug Administration / First DataBank / Pharmaceutical drug / Inflation / Pharmacy / Prescription medication / Prescription drug prices in the United States / Pharmaceutical sciences / Pharmacology / Pharmaceuticals policy


Microsoft Word - kessler-pricecontrols.doc
Add to Reading List

Open Document

File Size: 50,66 KB

Share Result on Facebook

Company

First DataBank / /

Country

Germany / United States / Netherlands / Canada / New Zealand / /

Currency

USD / /

Facility

National Center / Empirical Literature Daniel P. Kessler Stanford University / /

IndustryTerm

retail pharmacies / pharmaceutical prices / pharmaceuticals / less stringent systems / pharmaceutical price regulation / pharmaceutical industry / pharmaceutical innovation / pharmaceutical use / chemical entities / less innovative new products / reference pricing systems / less stringent reference pricing systems / pharmaceutical / aggregate pharmaceutical margins / treatment of each disease / pharmaceutical firms / pharmaceutical knowledge accumulation / reference / /

MedicalCondition

disease / malaria / diseases / each disease / illness / /

Organization

Hoover Institution / Stanford University / National Center for Health Statistics / FDA / OECD / National Bureau / /

Person

Clinton / /

Position

author / President / major US pharmaceutical companies / /

SportsLeague

Stanford University / /

SocialTag